Multiple myeloma:: Increase of the effectiveness of Velcade® (Bortezomib) through combination therapy

被引：0
|
作者：
Aschoff, K
机构：
来源：
TRANSFUSION MEDICINE AND HEMOTHERAPY | 2005年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [1] Multiple myeloma:: Increase of the effectiveness of Velcade® (Bortezomib) through combination therapy
    不详
    ONKOLOGIE, 2005, 28 (11): : 608 - 608
  • [2] Bortezomib (Velcade) for multiple myeloma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1161): : 57 - 58
  • [3] Cost-effectiveness of bortezomib (VELCADE) for relapsed and refractory multiple myeloma
    Bagust, A
    Haycox, A
    Mujica-Mota, R
    Dhawan, R
    Dubois, D
    VALUE IN HEALTH, 2004, 7 (06) : 670 - 670
  • [4] Bortezomib Combination Therapy in Multiple Myeloma
    Kapoor, Prashant
    Ramakrishnan, Vijay
    Rajkumar, S. Vincent
    SEMINARS IN HEMATOLOGY, 2012, 49 (03) : 228 - 242
  • [5] CLINICAL EFFICACY OF VELCADE (BORTEZOMIB) AND DEXAMETHASONE THERAPY IN PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA
    Ionita, I.
    Cheveresan, M.
    Calamar, D.
    Ionita, C.
    Oros, D.
    Ionita, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 627 - 628
  • [6] A Phase I/II Study of Bortezomib (VELCADE) in Combination with Pralatrexate in Relapsed/Refractory Multiple Myeloma
    Dunn, Tamara J.
    Dinner, Shira N.
    Berube, Caroline
    Gotlib, Jason
    Coutre, Steven E.
    Medeiros, Bruno C.
    Liedtke, Michaela
    BLOOD, 2012, 120 (21)
  • [7] BORTEZOMIB IN COMBINATION WITH CYTOTOXIC AGENT THERAPY FOR MULTIPLE MYELOMA
    Takamatsu, Y.
    Sunami, K.
    Miyamoto, T.
    Hata, H.
    Muta, T.
    Tsukada, J.
    Uozumi, K.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [8] How best to use bortezomib (Velcade (R)) in multiple myeloma
    Rousselot, Philippe
    HEMATOLOGIE, 2006, 12 (05): : 300 - 300
  • [9] The effect of bortezomib (VELCADE) on bone disease in multiple myeloma.
    Terpos, E
    Politou, M
    Armstrong, L
    Henderson, C
    Kanfer, E
    Apperley, JF
    Goldman, JM
    Rahemtulla, A
    BLOOD, 2003, 102 (11) : 390B - 390B
  • [10] Economic evaluation of bortezomib (VELCADE) for relapsed and refractory multiple myeloma
    Bagust, A
    Haycox, AR
    Boland, A
    Chu, P
    Morgan, GJ
    Mota, REM
    Dubois, D
    Dhawan, R
    BLOOD, 2004, 104 (11) : 80A - 80A
12345